Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial
Sabatine, Marc S, Dr, Antman, Elliott M, Prof, Widimsky, Petr, Prof, Ebrahim, Iftikhar O, MBBCh, Kiss, Robert G, MD, Saaiman, André, MD, Polasek, Rostislav, MD, Contant, Charles F, PhD, McCabe, Carolyn H, BS, Braunwald, Eugene, Prof
Published in The Lancet (British edition) (05.09.2009)
Published in The Lancet (British edition) (05.09.2009)
Get full text
Journal Article